Key clinical point: Vitamin E acetate appeared in the bronchoalveolar-lavage (BAL) fluid of 94% of EVALI patients, but not in healthy controls.
Major finding: Vitamin E acetate was identified in BAL samples of 48 of 51 EVALI patients in 16 states.
Study details: The data come from a review of 51 adults with EVALI and 99 healthy controls.
Disclosures: The study was supported in part by the National Cancer Institute, the FDA Center for Tobacco Products, and Ohio State University Pelotonia Intramural Research. The researchers had no financial conflicts to disclose.
Blount BC et al. N Engl J Med. 2020 Feb 20. doi: 10.1056/NEJMoa1916433.